Bioidentical hormones vs standard HRT: what is the difference?

Short answer

• “Bioidentical” hormones are molecules that have the exact same chemical structure as the hormones produced by the human body (for example 17β‑estradiol, micronized progesterone).
• “Standard” HRT (hormone replacement therapy) can use either bioidentical hormones or non‑bioidentical (synthetic or animal‑derived) hormones — and includes FDA‑approved products with standardized doses, labeling, and safety data.
• The main practical differences are how the products are made, regulated and tested — not the idea that “bioidentical” products are automatically safer or more effective.

Definitions and examples

• Bioidentical: chemically identical to human hormones. Examples available as FDA‑approved products include estradiol tablets and patches (Estrace, Vivelle‑Dot, Climara, Alora), estradiol vaginal products (Vagifem, Estring), and micronized progesterone (Prometrium).
• Non‑bioidentical / standard HRT: includes conjugated equine estrogens (Premarin) and synthetic progestins (medroxyprogesterone acetate — Provera), plus other FDA‑approved estrogen/progestin combinations.

Compounded “bioidentical” hormones

• Many compounding pharmacies make custom mixtures (creams, troches, capsules) and label them “bioidentical.” These are not FDA‑approved products. They are made to individual prescriptions and may include combinations or doses not available commercially.
• Risks of compounded products: variable potency and purity, inconsistent dosing between batches, fewer safety and efficacy studies, and less regulatory oversight. FDA has warned consumers about unsupported safety claims by some compounding vendors.

Safety and effectiveness

• FDA‑approved HRT products have gone through quality control and clinical testing; their risks and benefits are better documented.
• There is no high‑quality evidence that compounded bioidentical hormones are safer or more effective than FDA‑approved HRT.
• Common HRT risks (some depending on type, dose, route, and whether progesterone is used): increased risk of venous thromboembolism (higher with oral estrogens), possible increased breast cancer risk with combined estrogen‑progestin (as seen in WHI for certain formulations), stroke, and cardiovascular effects (risk varies by age and years since menopause).
• Some differences by formulation: transdermal estradiol (patch) is associated with lower VTE risk than oral estrogen in many studies. Micronized progesterone (Prometrium) may have a different safety profile than synthetic progestins, but data are not definitive.

Common misconceptions

• “Natural” or “bioidentical” does not automatically mean safer.
• Saliva hormone testing used to “tailor” doses is not a validated method for guiding menopausal HRT dosing.
• Compounded preparations are not always necessary; many needs can be met with commercial, FDA‑approved products.

When a compounded product may be considered

• If you have a true allergy to an ingredient in all FDA‑approved options,
• If you need a dose or combination not commercially available and after discussing risks/benefits,
• Then use a licensed, reputable compounding pharmacy and clear documentation for follow‑up.

Practical advice

• Discuss goals (hot flashes, night sweats, vaginal dryness, bone protection), medical history (personal/family history of breast cancer, clotting disorders, cardiovascular disease), and risk factors with your clinician.
• Prefer FDA‑approved products when possible for predictable dosing and safety data.
• Consider route: vaginal products for local dyspareunia/vaginal atrophy; transdermal patches/gels to reduce VTE risk for those at higher clot risk; oral options for convenience in some people.
• Use the lowest effective dose for the shortest time needed, and have periodic reassessment.
• If considering compounded BHRT, ask about lot testing, stability, sterility, credentials of the pharmacy, and avoid relying on saliva tests.

If you want, I can:

• Compare specific products that match your symptoms and risk profile (e.g., transdermal estradiol patch brands vs oral tablets),
• Explain progesterone vs progestin choices for uterine protection,
• Or summarize risks tailored to your age and medical history.